Hôpital universitaire Necker - Enfants Malades

Paris 75743

6 studies enrolling now · 9 studies all time

What they study most

Anemia, Anemia, Sickle Cell, Diabetes Mellitus, Type 1, Exostoses, Multiple Hereditary, Healthy Volunteers, Hemophilia A, Hemophilia B, Hypochondroplasia, Multiple Myeloma, Type 1 Diabetes Mellitus

Studies at this site

• A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) — Recruiting now
• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — Recruiting now
• MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) — Recruiting now
• A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease — Recruiting now
• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors — Recruiting now
• Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia — Enrolling by invitation
• An Efficacy and Safety Study of Palovarotene for the Treatment of MO — Stopped early
• A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes — Completed
• Age of Blood in Children in Pediatric Intensive Care Units — Completed